Ardelyx Inc Stock - ARDX Share Price Today, News and Discussion

Ardelyx, Inc. is a biopharmaceutical company. engages in the research, development and commercialization of medicine for the treatment of cardiorenal diseases. Its product portfolio includes tenapanor, which is an experimental medication that works exclusively in the gut and is in late-stage clinical development. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet on October 17, 2007 and is headquartered in Fremont, CA.

Sector:

Health Technology

Industry:

Pharmaceuticals Major

Employees:

86

Current Price	$3.28
Prev Close	$3.35
Open	$3.30
Dividend Yield	0.00%
50-Day Moving Average	$2.45
Beta	0.95
Avg. Volume	6.95M
PE Ratio	N/A

52-Week High	$3.43
52-Week Low	$0.4902
Market Capitalization	$577.38M
EPS	-$0.8525
Price to Book	8.63
Revenue Per Employee	$104,755.81
Enterprise Value/EBITDA	-1.34

No ARDX news at the moment.

ARDX Ardelyx Inc

About

Feed

Fundamentals

News